Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease

BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonell, Katherine E., van Wouwe, Nelleke C., Harrison, Madaline B., Wylie, Scott A., Claassen, Daniel O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043698/
https://www.ncbi.nlm.nih.gov/pubmed/29856137
http://dx.doi.org/10.1002/brb3.1008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043698/
https://www.ncbi.nlm.nih.gov/pubmed/29856137
http://dx.doi.org/10.1002/brb3.1008

Ejemplares similares